1921
Volume 93, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

Skin ulcer development in cutaneous leishmaniasis due to infection is associated with a mononuclear cell infiltrate and high levels of tumor necrosis factor (TNF). Herein, we show that despite the absence of -driven TNF, a cutaneous leishmaniasis patient with acquired immunodeficiency syndrome developed a skin ulcer. The presence of mononuclear phagocytes and high levels of TNF, chemokine (C-C motif) ligand 2 (CCL2), and metalloproteinase-9 in tissue are identified as potential contributors to immunopathology observed in -infected patients.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.14-0475
2015-12-09
2020-06-07
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/6/1219.html?itemId=/content/journals/10.4269/ajtmh.14-0475&mimeType=html&fmt=ahah

References

  1. Carvalho LP, Passos S, Bacellar O, Lessa M, Almeida RP, Magalhaes A, Dutra WO, Gollob KJ, Machado P, de Jesus AR, 2007. Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite Immunol 29: 251258.[Crossref]
    [Google Scholar]
  2. Passos S, Carvalho LP, Costa RS, Campos TM, Novais FO, Magalhaes A, Machado PR, Beiting D, Mosser D, Carvalho EM, Scott P, 2015. Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections. J Infect Dis 211: 274282.[Crossref]
    [Google Scholar]
  3. Cardoso TM, Machado A, Costa DL, Carvalho LP, Queiroz A, Machado P, Scott P, Carvalho EM, Bacellar O, 2015. Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection. Infect Immun 83: 898906.[Crossref]
    [Google Scholar]
  4. Novais FO, Carvalho LP, Graff JW, Beiting DP, Ruthel G, Roos DS, Betts MR, Goldschmidt MH, Wilson ME, de Oliveira CI, Scott P, 2013. Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. PLoS Pathog 9: e1003504.[Crossref]
    [Google Scholar]
  5. Santos C da S, Boaventura V, Ribeiro Cardoso C, Tavares N, Lordelo MJ, Noronha A, Costa J, Borges VM, de Oliveira CI, Van Weyenbergh J, Barral A, Barral-Netto M, Brodskyn CI, 2013. CD8+ granzyme B+–mediated tissue injury vs. CD4+ IFNγ+–mediated parasite killing in human cutaneous leishmaniasis. J Invest Dermatol 133: 15331540.[Crossref]
    [Google Scholar]
  6. Faria DR, Souza PE, Duraes FV, Carvalho EM, Gollob KJ, Machado PR, Dutra WO, 2009. Recruitment of CD8+ T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol 31: 432439.[Crossref]
    [Google Scholar]
  7. Ezra N, Ochoa MT, Craft N, 2010. Human immunodeficiency virus and leishmaniasis. J Glob Infect Dis 2: 248257.[Crossref]
    [Google Scholar]
  8. Ngouateu OB, Kollo P, Ravel C, Dereure J, Kamtchouing P, Same-Ekobo A, von Stebut E, Maurer M, Dondji B, 2012. Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional study. Trans R Soc Trop Med Hyg 106: 137142.[Crossref]
    [Google Scholar]
  9. Alvar J, Aparicio P, Aseffa A, Den Boer M, Canavate C, Dedet JP, Gradoni L, Ter Horst R, Lopez-Velez R, Moreno J, 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334359; table of contents.[Crossref]
    [Google Scholar]
  10. Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, Gollob KJ, Carvalho EM, 2002. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 70: 67346740.[Crossref]
    [Google Scholar]
  11. Erikstrup C, Kallestrup P, Zinyama R, Gomo E, Mudenge B, Gerstoft J, Ullum H, 2007. Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa. J Acquir Immune Defic Syndr 44: 478483.[Crossref]
    [Google Scholar]
  12. Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, Heine GH, 2011. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118: e50e61.[Crossref]
    [Google Scholar]
  13. Maretti-Mira AC, de Pinho Rodrigues KM, de Oliveira-Neto MP, Pirmez C, Craft N, 2011. MMP-9 activity is induced by Leishmania braziliensis infection and correlates with mucosal leishmaniasis. Acta Trop 119: 160164.[Crossref]
    [Google Scholar]
  14. Campos TM, Passos ST, Novais FO, Beiting DP, Costa RS, Queiroz A, Mosser D, Scott P, Carvalho EM, Carvalho LP, 2014. Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous leishmaniasis. PLoS Negl Trop Dis 8: e3282.[Crossref]
    [Google Scholar]
  15. Weirather JL, Jeronimo SM, Gautam S, Sundar S, Kang M, Kurtz MA, Haque R, Schriefer A, Talhari S, Carvalho EM, Donelson JE, Wilson ME, 2011. Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples. J Clin Microbiol 49: 38923904.[Crossref]
    [Google Scholar]
  16. Barbosa T, Arruda S, Fernandes BD, Carvalho LP, Cardoso S, Cunha S, Barreto ML, Pereira SM, Rodrigues LC, Barral-Netto M, 2003. BCG (Bacille of Calmette-Guerin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children. Vaccine 21: 21522160.[Crossref]
    [Google Scholar]
  17. Guimaraes LH, Machado PR, Lago EL, Morgan DJ, Schriefer A, Bacellar O, Carvalho EM, 2009. Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil. Trans R Soc Trop Med Hyg 103: 712715.[Crossref]
    [Google Scholar]
  18. Rodrigues MZ, Grassi MF, Mehta S, Zhang XQ, Gois LL, Schooley RT, Badaro R, 2011. Th1/Th2 cytokine profile in patients coinfected with HIV and Leishmania in Brazil. Clin Vaccine Immunol 18: 17651769.[Crossref]
    [Google Scholar]
  19. Antonelli LR, Dutra WO, Almeida RP, Bacellar O, Carvalho EM, Gollob KJ, 2005. Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett 101: 226230.[Crossref]
    [Google Scholar]
  20. Brito G, Dourado M, Polari L, Celestino D, Carvalho LP, Queiroz A, Carvalho EM, Machado PR, Passos S, 2014. Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline. Am J Trop Med Hyg 90: 617620.[Crossref]
    [Google Scholar]
  21. Unger A, O'Neal S, Machado PR, Guimaraes LH, Morgan DJ, Schriefer A, Bacellar O, Glesby MJ, Carvalho EM, 2009. Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil. Am J Trop Med Hyg 80: 574579.
    [Google Scholar]
  22. Giudice A, Vendrame C, Bezerra C, Carvalho LP, Delavechia T, Carvalho EM, Bacellar O, 2012. Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection. BMC Infect Dis 12: 75.[Crossref]
    [Google Scholar]
  23. Cordiali-Fei P, Trento E, D'Agosto G, Bordignon V, Mussi A, Ardigo M, Mastroianni A, Vento A, Solivetti F, Berardesca E, Ensoli F, 2006. Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha. J Autoimmune Dis 3: 5.[Crossref]
    [Google Scholar]
  24. Devillers AC, van Toorenenbergen AW, Klein Heerenbrink GJ, Muldert PG, Oranje AP, 2007. Elevated levels of plasma matrix metalloproteinase-9 in patients with atopic dermatitis: a pilot study. Clin Exp Dermatol 32: 311313.[Crossref]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0475
Loading
/content/journals/10.4269/ajtmh.14-0475
Loading

Data & Media loading...

Supplementary PDF

  • Received : 30 Jul 2014
  • Accepted : 22 Sep 2015
  • Published online : 09 Dec 2015
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error